These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


292 related items for PubMed ID: 2068317

  • 1. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol.
    Yuh WT, Fisher DJ, Engelken JD, Greene GM, Sato Y, Ryals TJ, Crain MR, Ehrhardt JC.
    Radiology; 1991 Aug; 180(2):485-91. PubMed ID: 2068317
    [Abstract] [Full Text] [Related]

  • 2. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
    Vogl TJ, Mack MG, Juergens M, Stark M, Pegios W, Bergman C, Grevers G, Western A.
    AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
    [Abstract] [Full Text] [Related]

  • 3. Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
    Haustein J, Laniado M, Niendorf HP, Louton T, Beck W, Planitzer J, Schöffel M, Reiser M, Kaiser W, Schörner W.
    Radiology; 1993 Mar; 186(3):855-60. PubMed ID: 8430199
    [Abstract] [Full Text] [Related]

  • 4. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
    Myhr G, Rinck PA, Børseth A.
    Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
    [Abstract] [Full Text] [Related]

  • 5. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients.
    Kuhn MJ, Hammer GM, Swenson LC, Youssef HT, Gleason TJ.
    Comput Med Imaging Graph; 1994 Sep; 18(5):391-9. PubMed ID: 7954317
    [Abstract] [Full Text] [Related]

  • 6. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
    Kopka L, Funke M, Fischer U, Keating D, Oestmann J, Grabbe E.
    AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
    [Abstract] [Full Text] [Related]

  • 7. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
    Strouse PJ, Prince MR, Chenevert TL.
    Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
    [Abstract] [Full Text] [Related]

  • 8. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
    Katakami N, Inaba Y, Sugata S, Tsurusaki M, Itoh T, Machida T, Tanaka H, Nakayama T, Morikawa T, Breuer J, Aitoku Y.
    Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
    [Abstract] [Full Text] [Related]

  • 9. Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent.
    Carvlin MJ, De Simone DN, Meeks MJ.
    Invest Radiol; 1992 Aug; 27 Suppl 1():S16-21. PubMed ID: 1506148
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
    Wang QJ, Wang Y, Xu X, Xiao H, Ma L.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
    [Abstract] [Full Text] [Related]

  • 11. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
    Knopp MV, Bourne MW, Sardanelli F, Wasser MN, Bonomo L, Boetes C, Müller-Schimpfle M, Hall-Craggs MA, Hamm B, Orlacchio A, Bartolozzi C, Kessler M, Fischer U, Schneider G, Oudkerk M, Teh WL, Gehl HB, Salerio I, Pirovano G, La Noce A, Kirchin MA, Spinazzi A.
    AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457
    [Abstract] [Full Text] [Related]

  • 12. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Knopp MV, Runge VM, Essig M, Hartman M, Jansen O, Kirchin MA, Moeller A, Seeberg AH, Lodemann KP.
    Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
    [Abstract] [Full Text] [Related]

  • 13. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine.
    Heywang-Köbrunner SH, Haustein J, Pohl C, Beck R, Lommatzsch B, Untch M, Nathrath WB.
    Radiology; 1994 Jun; 191(3):639-46. PubMed ID: 8184040
    [Abstract] [Full Text] [Related]

  • 14. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
    Jung HW, Chang KH, Choi DS, Han MH, Han MC.
    AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
    [Abstract] [Full Text] [Related]

  • 15. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
    Jensen MC, Brant-Zawadzki M.
    AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
    [Abstract] [Full Text] [Related]

  • 16. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU, Reiser MF, Huber AM.
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [Abstract] [Full Text] [Related]

  • 17. MR imaging of pituitary region lesions with gadodiamide injection.
    Hald JK, Skalpe IO, Bakke SJ, Nakstad PH.
    Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
    [Abstract] [Full Text] [Related]

  • 18. Magnetic resonance imaging contrast agents.
    Runge VM.
    Curr Opin Radiol; 1992 Feb; 4(1):3-12. PubMed ID: 1739599
    [Abstract] [Full Text] [Related]

  • 19. Gd-HP-DO3A in clinical MR imaging of the brain.
    Runge VM, Gelblum DY, Pacetti ML, Carolan F, Heard G.
    Radiology; 1990 Nov; 177(2):393-400. PubMed ID: 2217775
    [Abstract] [Full Text] [Related]

  • 20. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects.
    Jinkins JR, Rauch RA, Gee GT, Bazan C, Xiong L, Kashanian FK, Hanna EP.
    Radiology; 1995 Oct; 197(1):247-51. PubMed ID: 7568831
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.